Scarica l'app Stockscreener
1.22
10.62%
-0.145
Dopo l'orario di chiusura:
1.27
0.05
+4.10%
Precedente Chiudi:
$1.365
Aprire:
$1.4148
Volume 24 ore:
98,593
Relative Volume:
1.23
Capitalizzazione di mercato:
$9.36M
Reddito:
$598.00K
Utile/perdita netta:
$-44.93M
Rapporto P/E:
-0.1468
EPS:
-8.31
Flusso di cassa netto:
$-17.32M
1 W Prestazione:
-11.59%
1M Prestazione:
-21.79%
6M Prestazione:
-71.55%
1 anno Prestazione:
-95.26%
Intervallo 1D:
$1.21
$1.4665
Intervallo di 1 settimana:
$1.21
$1.4665
Portata 52W:
$1.21
$26.60
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Nome
Ernexa Therapeutics Inc
Settore
Industria
Telefono
(617) 798-6700
Indirizzo
1035 CAMBRIDGE STREET, CAMBRIDGE
Confronta ERNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.22 | 9.86M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Borsa (ERNA) Ultime notizie
Volume spikes in Ernexa Therapeutics Inc. stock – what they mean2025 Biggest Moves & Precise Entry and Exit Recommendations - Newser
How to integrate Ernexa Therapeutics Inc. into portfolio analysis toolsQuarterly Risk Review & Weekly Stock Breakout Alerts - Newser
Heatmap analysis for Ernexa Therapeutics Inc. and competitorsPortfolio Profit Report & Daily Oversold Bounce Ideas - Newser
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference - The Globe and Mail
Ernexa Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - Quiver Quantitative
Novel Off-the-Shelf Cell Therapy: Ernexa to Present Cancer Treatment Pipeline Advancing to Clinic 2026 - Stock Titan
Candlestick signals on Ernexa Therapeutics Inc. stock todayEarnings Beat & Reliable Trade Execution Plans - Newser
What’s the recovery path for long term holders of Ernexa Therapeutics Inc.2025 Market Outlook & Smart Money Movement Tracker - Newser
How to interpret RSI for Ernexa Therapeutics Inc. stock2025 Price Targets & Smart Allocation Stock Reports - Newser
What’s next for Ernexa Therapeutics Inc. stock priceMarket Growth Report & Fast Momentum Stock Entry Tips - Newser
What does recent volatility data suggest for Ernexa Therapeutics Inc.Weekly Stock Summary & AI Powered Market Entry Ideas - Newser
Ranking Ernexa Therapeutics Inc. among high performing stocks via toolsEarnings Trend Report & Advanced Swing Trade Entry Alerts - Newser
Long term hold vs stop loss in Ernexa Therapeutics Inc.2025 Volume Leaders & Real-Time Volume Analysis - Newser
Evaluating Ernexa Therapeutics Inc. with trendline analysisJuly 2025 Short Interest & Growth Focused Entry Reports - Newser
Will Ernexa Therapeutics Inc. stock recover after earningsShare Buyback & Smart Allocation Stock Tips - khodrobank.com
Using data tools to time your Ernexa Therapeutics Inc. exitJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser
Does Ernexa Therapeutics Inc. fit your quant trading modelEarnings Growth Report & Weekly Breakout Stock Alerts - Newser
Published on: 2025-09-02 10:13:31 - Newser
What is the earnings history of Ernexa Therapeutics Inc.2025 Key Highlights & Weekly Chart Analysis and Trade Guides - khodrobank.com
Can swing trading help recover from Ernexa Therapeutics Inc. lossesSwing Trade & Advanced Technical Analysis Signals - Newser
Can Ernexa Therapeutics Inc. deliver alphaJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - khodrobank.com
Visualizing Ernexa Therapeutics Inc. stock with heatmapsCEO Change & Verified Short-Term Plans - Newser
Is Ernexa Therapeutics Inc. a speculative investmentQuarterly Investment Review & AI Powered Trade Plan Recommendations - khodrobank.com
Ernexa Therapeutics Inc. stock trend forecastJuly 2025 Analyst Calls & Short-Term High Return Ideas - Newser
Has Ernexa Therapeutics Inc. found a price floor2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser
Is Ernexa Therapeutics Inc. Starting a New Uptrend getLinesFromResByArray error: size == 0 - thegnnews.com
Ernexa Therapeutics Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Will Ernexa Therapeutics Inc. stock benefit from AI tech trendsVolume Spike & Pattern Based Trade Signal System - Newser
Ernexa Therapeutics Inc. stock outlook for YEARQuarterly Earnings Summary & Stepwise Trade Execution Plans - Newser
Forecasting Ernexa Therapeutics Inc. price range with options dataMarket Weekly Review & Weekly Chart Analysis and Trade Guides - Newser
Is Ernexa Therapeutics Inc. forming a bottoming baseEarnings Miss & Real-Time Volume Analysis Alerts - Newser
Technical Models Suggest Ernexa Therapeutics Inc. May Rebound Soon getLinesFromResByArray error: size == 0 - newsyoung.net
Published on: 2025-08-31 00:51:50 - Newser
Full technical analysis of Ernexa Therapeutics Inc. stock2025 Top Gainers & Daily Profit Maximizing Tips - Newser
Exit strategy if you’re trapped in Ernexa Therapeutics Inc.2025 Performance Recap & Stepwise Trade Execution Plans - Newser
Will Ernexa Therapeutics Inc. see short term momentumTrade Exit Report & Low Drawdown Trading Strategies - Newser
What to expect from Ernexa Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser
Why Ernexa Therapeutics Inc. stock attracts strong analyst attentionQuarterly Earnings Report & Technical Pattern Recognition Alerts - Newser
Ernexa Therapeutics Inc Azioni (ERNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ernexa Therapeutics Inc Azioni (ERNA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):